Home | News | Find a Doctor | Ask a Question | Free

"Pfizer Eyes Up UK Minnow" - Sunday Times


#1

Item in the Sunday Times today suggests that Pfizer is among a number of interested parties bidding for Intercytex which is currently valued at £10.5m.

The other parties aren’t named but you I guess Pfizer must have the deepest pockets and are apparently looking to fund stem cell research into AMD blindness which intercytex have knowledge of via their recent company purchase.

Presumably, they would also continue research into Intercytex’s other products which can only be good news for us although what this does to the timeline is anyone’s guess.


#2

» Item in the Sunday Times today suggests that Pfizer is among a number of
» interested parties bidding for Intercytex which is currently valued at
» £10.5m.
»
» The other parties aren’t named but you I guess Pfizer must have the
» deepest pockets and are apparently looking to fund stem cell research into
» AMD blindness which intercytex have knowledge of via their recent company
» purchase.
»
» Presumably, they would also continue research into Intercytex’s other
» products which can only be good news for us although what this does to the
» timeline is anyone’s guess.

Okay, now its the poor blind people, yesterday it was the poor old people with VLUs. It seems that everyone is a priority except us, the bald guys.
In the meantime, many bald guys will fell ill and some even die because of the usage for decades of innappropriate treatments like Finasteride and Minoxidil. Oh, but who cares! they are just bald guys!


#3

» Item in the Sunday Times today suggests that Pfizer is among a number of
» interested parties bidding for Intercytex which is currently valued at
» £10.5m.
»
» The other parties aren’t named but you I guess Pfizer must have the
» deepest pockets and are apparently looking to fund stem cell research into
» AMD blindness which intercytex have knowledge of via their recent company
» purchase.
»
» Presumably, they would also continue research into Intercytex’s other
» products which can only be good news for us although what this does to the
» timeline is anyone’s guess.

Pfizer is no idiots, if they can take over Intercytex, this is good news.


#4

» » Item in the Sunday Times today suggests that Pfizer is among a number of
» » interested parties bidding for Intercytex which is currently valued at
» » £10.5m.
» »
» » The other parties aren’t named but you I guess Pfizer must have the
» » deepest pockets and are apparently looking to fund stem cell research
» into
» » AMD blindness which intercytex have knowledge of via their recent
» company
» » purchase.
» »
» » Presumably, they would also continue research into Intercytex’s other
» » products which can only be good news for us although what this does to
» the
» » timeline is anyone’s guess.
»
» Pfizer is no idiots, if they can take over Intercytex, this is good news.

Former investors on ICX were no idiots either.
Maybe Pfizer is just trying to speculate with ICX, to make a profit. Now ICX stocks are on the floor. Buy, speculate, make them rise, and sell.


#5

A likely scenario is a repeat of what happened to neosilosh. Pfizer might be interested in ICX’s blindness treatment, buy the company ditch the questionable project ( hair multiplication, vavelta) focus resources only on what they want, thus ending intercyrex hair projects


#6

Pfizer doesn’t have to go out and terminate anything in order to get the TRC project closed up. ICX won’t do phase III on their own anyway.